Plasmid DNA Manufacturing Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2021 - 2027

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Plasmid DNA Manufacturing Market, By Disease

7.1. Plasmid DNA Manufacturing Market, by Disease Type, 2020-2027

7.1.1. Infectious Disease

7.1.1.1. Market Revenue and Forecast (2016-2027)

7.1.2. Cancer

7.1.2.1. Market Revenue and Forecast (2016-2027)

7.1.3. Genetic Disorder

7.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global Plasmid DNA Manufacturing Market, By Application

8.1. Plasmid DNA Manufacturing Market, by Application, 2020-2027

8.1.1. Gene Therapy

8.1.1.1. Market Revenue and Forecast (2016-2027)

8.1.2. Vaccinology

8.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Plasmid DNA Manufacturing Market, By End use 

9.1. Plasmid DNA Manufacturing Market, by End use, 2020-2027

9.1.1. Research Institute

9.1.1.1. Market Revenue and Forecast (2016-2027)

9.1.2. Biotech Companies

9.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Plasmid DNA Manufacturing Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Disease (2016-2027)

10.1.2. Market Revenue and Forecast, by Application (2016-2027)

10.1.3. Market Revenue and Forecast, by End use (2016-2027)

10.1.4. U.S.

10.1.4.1. Market Revenue and Forecast, by Disease (2016-2027)

10.1.4.2. Market Revenue and Forecast, by Application (2016-2027)

10.1.4.3. Market Revenue and Forecast, by End use (2016-2027)

10.1.5. Rest of North America

10.1.5.1. Market Revenue and Forecast, by Disease (2016-2027)

10.1.5.2. Market Revenue and Forecast, by Application (2016-2027)

10.1.5.3. Market Revenue and Forecast, by End use (2016-2027)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Disease (2016-2027)

10.2.2. Market Revenue and Forecast, by Application (2016-2027)

10.2.3. Market Revenue and Forecast, by End use (2016-2027)

10.2.4. UK

10.2.4.1. Market Revenue and Forecast, by Disease (2016-2027)

10.2.4.2. Market Revenue and Forecast, by Application (2016-2027)

10.2.4.3. Market Revenue and Forecast, by End use (2016-2027)

10.2.5. Germany

10.2.5.1. Market Revenue and Forecast, by Disease (2016-2027)

10.2.5.2. Market Revenue and Forecast, by Application (2016-2027)

10.2.5.3. Market Revenue and Forecast, by End use (2016-2027)

10.2.6. France

10.2.6.1. Market Revenue and Forecast, by Disease (2016-2027)

10.2.6.2. Market Revenue and Forecast, by Application (2016-2027)

10.2.6.3. Market Revenue and Forecast, by End use (2016-2027)

10.2.7. Rest of Europe

10.2.7.1. Market Revenue and Forecast, by Disease (2016-2027)

10.2.7.2. Market Revenue and Forecast, by Application (2016-2027)

10.2.7.3. Market Revenue and Forecast, by End use (2016-2027)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Disease (2016-2027)

10.3.2. Market Revenue and Forecast, by Application (2016-2027)

10.3.3. Market Revenue and Forecast, by End use (2016-2027)

10.3.4. India

10.3.4.1. Market Revenue and Forecast, by Disease (2016-2027)

10.3.4.2. Market Revenue and Forecast, by Application (2016-2027)

10.3.4.3. Market Revenue and Forecast, by End use (2016-2027)

10.3.5. China

10.3.5.1. Market Revenue and Forecast, by Disease (2016-2027)

10.3.5.2. Market Revenue and Forecast, by Application (2016-2027)

10.3.5.3. Market Revenue and Forecast, by End use (2016-2027)

10.3.6. Japan

10.3.6.1. Market Revenue and Forecast, by Disease (2016-2027)

10.3.6.2. Market Revenue and Forecast, by Application (2016-2027)

10.3.6.3. Market Revenue and Forecast, by End use (2016-2027)

10.3.7. Rest of APAC

10.3.7.1. Market Revenue and Forecast, by Disease (2016-2027)

10.3.7.2. Market Revenue and Forecast, by Application (2016-2027)

10.3.7.3. Market Revenue and Forecast, by End use (2016-2027)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Disease (2016-2027)

10.4.2. Market Revenue and Forecast, by Application (2016-2027)

10.4.3. Market Revenue and Forecast, by End use (2016-2027)

10.4.4. GCC

10.4.4.1. Market Revenue and Forecast, by Disease (2016-2027)

10.4.4.2. Market Revenue and Forecast, by Application (2016-2027)

10.4.4.3. Market Revenue and Forecast, by End use (2016-2027)

10.4.5. North Africa

10.4.5.1. Market Revenue and Forecast, by Disease (2016-2027)

10.4.5.2. Market Revenue and Forecast, by Application (2016-2027)

10.4.5.3. Market Revenue and Forecast, by End use (2016-2027)

10.4.6. South Africa

10.4.6.1. Market Revenue and Forecast, by Disease (2016-2027)

10.4.6.2. Market Revenue and Forecast, by Application (2016-2027)

10.4.6.3. Market Revenue and Forecast, by End use (2016-2027)

10.4.7. Rest of MEA

10.4.7.1. Market Revenue and Forecast, by Disease (2016-2027)

10.4.7.2. Market Revenue and Forecast, by Application (2016-2027)

10.4.7.3. Market Revenue and Forecast, by End use (2016-2027)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Disease (2016-2027)

10.5.2. Market Revenue and Forecast, by Application (2016-2027)

10.5.3. Market Revenue and Forecast, by End use (2016-2027)

10.5.4. Brazil

10.5.4.1. Market Revenue and Forecast, by Disease (2016-2027)

10.5.4.2. Market Revenue and Forecast, by Application (2016-2027)

10.5.4.3. Market Revenue and Forecast, by End use (2016-2027)

10.5.5. Rest of LATAM

10.5.5.1. Market Revenue and Forecast, by Disease (2016-2027)

10.5.5.2. Market Revenue and Forecast, by Application (2016-2027)

10.5.5.3. Market Revenue and Forecast, by End use (2016-2027)

Chapter 11. Company Profiles

11.1. Akron Biotech

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Cobra Biologics Limited

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. VGXI, Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Aldevron

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. PlasmidFactory GmbH & Co. KG

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. LakePharma, Inc.

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Delphi Genetics

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Waisman Biomanufacturing

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Richter-Helm BioLogics

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Eurogentec

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms